Observation study of the relationship between intestinal bacterial flora and therapeutic effect or adverse events on advanced non-small cell lung cancer patients treated with nivolumab.

ABSTRACT: Primary outcome(s): Relationship between intestinal bacterial flora and therapeutic effect of nivolumab.

DISEASE(S): Non-small-cell Lung Cancer

PROVIDER: 2641596 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR